These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35867701)

  • 41. Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions.
    Tajabadi M; Goran Orimi H; Ramzgouyan MR; Nemati A; Deravi N; Beheshtizadeh N; Azami M
    Biomed Pharmacother; 2022 Feb; 146():112584. PubMed ID: 34968921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tunable biomaterials for myocardial tissue regeneration: promising new strategies for advanced biointerface control and improved therapeutic outcomes.
    Goonoo N
    Biomater Sci; 2022 Mar; 10(7):1626-1646. PubMed ID: 35230359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stem cells and injectable hydrogels: Synergistic therapeutics in myocardial repair.
    Sepantafar M; Maheronnaghsh R; Mohammadi H; Rajabi-Zeleti S; Annabi N; Aghdami N; Baharvand H
    Biotechnol Adv; 2016; 34(4):362-379. PubMed ID: 26976812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concise Review: Reduction of Adverse Cardiac Scarring Facilitates Pluripotent Stem Cell-Based Therapy for Myocardial Infarction.
    Liang J; Huang W; Jiang L; Paul C; Li X; Wang Y
    Stem Cells; 2019 Jul; 37(7):844-854. PubMed ID: 30913336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Material-based engineering strategies for cardiac regeneration.
    Marion MH; Bax NA; Spreeuwel AC; van der Schaft DW; Bouten CV
    Curr Pharm Des; 2014; 20(12):2057-68. PubMed ID: 23886381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical Engineering of Cell Therapy for Heart Diseases.
    Li Z; Hu S; Cheng K
    Acc Chem Res; 2019 Jun; 52(6):1687-1696. PubMed ID: 31125198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction.
    Wang Z; Long DW; Huang Y; Chen WCW; Kim K; Wang Y
    Acta Biomater; 2019 Mar; 87():140-151. PubMed ID: 30710713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineering stem cell therapeutics for cardiac repair.
    Fang J; Li JJ; Zhong X; Zhou Y; Lee RJ; Cheng K; Li S
    J Mol Cell Cardiol; 2022 Oct; 171():56-68. PubMed ID: 35863282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.
    Shafei AE; Ali MA; Ghanem HG; Shehata AI; Abdelgawad AA; Handal HR; Talaat KA; Ashaal AE; El-Shal AS
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29044850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction.
    Hasan A; Khattab A; Islam MA; Hweij KA; Zeitouny J; Waters R; Sayegh M; Hossain MM; Paul A
    Adv Sci (Weinh); 2015 Nov; 2(11):1500122. PubMed ID: 27668147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-based therapies for the treatment of myocardial infarction: lessons from cardiac regeneration and repair mechanisms in non-human vertebrates.
    Palmquist-Gomes P; Pérez-Pomares JM; Guadix JA
    Heart Fail Rev; 2019 Jan; 24(1):133-142. PubMed ID: 30421074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Injectable hydrogel with dual-sensitive behavior for targeted delivery of oncostatin M to improve cardiac restoration after myocardial infarction.
    Jiang YL; Niu S; Lin Z; Li L; Yang P; Rao P; Yang L; Jiang L; Sun L
    J Mater Chem B; 2022 Aug; 10(34):6514-6531. PubMed ID: 35997155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyaluronate supports hESC-cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction.
    Tan Y; Wang L; Chen G; Liu W; Li Z; Wang Y; Wang L; Li W; Wu J; Hao J
    Cell Prolif; 2020 Dec; 53(12):e12942. PubMed ID: 33107673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Materials science and tissue engineering: repairing the heart.
    Radisic M; Christman KL
    Mayo Clin Proc; 2013 Aug; 88(8):884-98. PubMed ID: 23910415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapies to prevent post-infarction remodelling: From repair to regeneration.
    Contessotto P; Pandit A
    Biomaterials; 2021 Aug; 275():120906. PubMed ID: 34139506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-infarct cardiac injury, protection and repair: roles of non-cardiomyocyte multicellular and acellular components.
    Du X
    Sci China Life Sci; 2018 Mar; 61(3):266-276. PubMed ID: 29388041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The amelioration of cardiac dysfunction after myocardial infarction by the injection of keratin biomaterials derived from human hair.
    Shen D; Wang X; Zhang L; Zhao X; Li J; Cheng K; Zhang J
    Biomaterials; 2011 Dec; 32(35):9290-9. PubMed ID: 21885119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of the Notch Signaling Pathway in Recovery of Cardiac Function after Myocardial Infarction.
    Kachanova O; Lobov A; Malashicheva A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering.
    Kharaziha M; Memic A; Akbari M; Brafman DA; Nikkhah M
    Adv Healthc Mater; 2016 Jul; 5(13):1533-53. PubMed ID: 27199266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.